Raj Chovatiya Discussed Conditions Mimicking Atopic Dermatitis at AAD Meeting and Highlighted the Shift Toward Targeted Therapies | AAD 2024
The clinical associate professor at the Rosalind Franklin University Chicago Medical School and founder and director of the Center for Medical Dermatology and Immunology Research in Chicago, spoke in a session over the weekend at the American Academy Dermatology meeting about conditions that may mimic atopic dermatitis.
Over the weekend, Raj J. Chovatiya, M.D., Ph.D, clinical associate professor at the Rosalind Franklin University Chicago Medical School and founder and director of the Center for Medical Dermatology and Immunology Research in Chicago, spoke in a session at the American Academy Dermatology meeting about conditions that may mimic atopic dermatitis.
Chovatiya advised against reflexively diagnosing atopic dermatitis solely based on itchiness and dermatitis, highlighting the importance of criteria and considering various diagnostic systems. If treatment doesn't yield expected results, he suggested pausing and reassessing, as atopic dermatitis is a clinical diagnosis but may benefit from diagnostics like blood work and biopsy for other conditions.
Regarding the dermatology meeting, he noted the shift toward targeted therapies this year, emphasizing innovation and the need to understand and incorporate novel therapeutics into daily practice.
Are High Doses of Skyrizi a Cure for Plaque Psoriasis? | AAD 2024
March 10th 2024A "hit-it-hard, hit-it-early" strategy might eventually cure plaque psoriasis, said Andrew Blauvelt, M.D., MBA. Blauvelt presented promising data from his small study of high-dose Skyrizi (risankizumab), but the doses were not a cure and the disease "trickles back" albeit slowly, he said.
Read More
